Kurt Gielen, Managing Director of Medace: Why U.S. MedTech Leaders Can’t Ignore Europe’s MedTech Shake-Up
Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever.
Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever.
Some of the most innovative leaders in the Medical Technology industry don’t arrive there through a straight line, and that’s certainly the case with Brian Kieser. Before founding Nvision Biomedical Technologies and building one of the most integrated innovation ecosystems in the industry, Brian was a mechanical engineering student, then an accountant, and eventually a certified public accountant (CPA) at KPMG. From technical schematics to financial audits, he’s seen every layer of how a business is built successfully.
We sit down with Brian More, CEO of Nanovis, for a candid conversation on strategy, science, and scaling up smart. From startup grit to a groundbreaking collaboration with Medtronic, Brian shares how Nanovis is transforming orthopedic and spinal implants through surface-level innovation, and why staying focused is the key to long-term success.
Founded as a spin-out from the University of Oxford, Brainomix has already transformed stroke care across Europe. With more than 70% market share in the UK and over 60 peer-reviewed publications validating its efficacy in real world settings, the company has delivered what few others can: evidence-based, scalable AI that improves outcomes and makes stroke systems more efficient.
“We often joke that we’re the Green Berets of quality,” says Monica Burt, founder of MB&A. “When things go sideways—an FDA audit is imminent, a system is unraveling, or a product launch is on life support—we get the call.”In this candid conversation with The MedTech Digest, Monica Burt pulls back the curtain on why most MedTech companies are doing quality all wrong—and how her team is helping them fix it before it breaks them. From debunking the myth that more paperwork equals more compliance, to rebuilding systems that actually enable innovation, Burt’s insights are equal parts sharp, strategic, and human.
Stryker has officially announced the sale of its U.S. spinal implants business to Viscogliosi Brothers (VB), paving the way for a new, specialized spine company
The company is at the forefront of transforming spine surgery by tackling some of the biggest challenges in healthcare…
I’ve learned and shared with people that whenever you have a major setback – whether study-related, study timeline change or product setback and timeline change, just reevaluate your whole approach and strategy because even with your well-laid plans, when one of the pieces of the plan changes, you realize other doors could open.
Orthopedic giants report record-breaking Q1 growth driven by the surge in robotic surgery. Explore the global market expansion.
I’ve been with Orlando Health for 15 years now, which is kind of crazy, and spent a lot of time on the marketing and digital side